Detalhe da pesquisa
1.
Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors.
Clin Pharmacokinet
; 63(5): 669-681, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38578394